Etya

Etya is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2345 references associated with Etya in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Etya

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Etya

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Airway Obstruction D000402 13 associated lipids
Arthus Reaction D001183 8 associated lipids
Blast Crisis D001752 2 associated lipids
Body Weight D001835 333 associated lipids
Catalepsy D002375 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Fever D005334 35 associated lipids
Glioma D005910 112 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hypertension D006973 115 associated lipids
Keratitis D007634 7 associated lipids
Pain D010146 64 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pasteurellosis, Pneumonic D012766 3 associated lipids
Thrombosis D013927 49 associated lipids
Trichinellosis D014235 9 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Hepatoblastoma D018197 10 associated lipids
Per page 10 20 | Total 19

NCBI Entrez Crosslinks

All references with Etya

Download all related citations
Per page 10 20 50 100 | Total 602
Authors Title Published Journal PubMed Link
Miller RC et al. Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. 1984 Br. J. Pharmacol. pmid:6151414
Nemeth EF and Douglas WW Differential inhibitory effects of the arachidonic acid analog ETYA on rat mast cell exocytosis evoked by secretagogues utilizing cellular or extracellular calcium. 1980 Eur. J. Pharmacol. pmid:6161012
Patterson R and Harris KE Inhibition of immunoglobulin E-mediated, antigen-induced monkey asthma and skin reactions by 5, 8, 11, 14-eicosatetraynoic acid. 1981 J. Allergy Clin. Immunol. pmid:6161146
Findlay SR et al. Hyperosmolar triggering of histamine release from human basophils. 1981 J. Clin. Invest. pmid:6165738
Marquardt DL et al. Lipid metabolism during mediator release from mast cells: studies of the role of arachidonic acid metabolism in the control of phospholipid metabolism. 1981 J. Immunol. pmid:6167627
Marone G et al. Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites. 1981 Int. Arch. Allergy Appl. Immunol. pmid:6171522
Nemeth EF and Douglas WW Lipoxygenase inhibitors exert secretagogue-specific effects on mast cell exocytosis. 1982 Eur. J. Pharmacol. pmid:6178611
Baldo BA Additional inhibitors of rat serum acute phase alpha 2-macroglobulin levels. Effect of 6-mercaptopurine and some lipoxygenase and cyclo-oxygenase inhibitors. 1982 Agents Actions pmid:6182776
Haye B et al. Effects of eicosatetraynoic acid (ETYA) on cultured pig thyroid cells. Relationships between the inhibition of the phosphatidate-phosphatidyl inositol cycle, the iodination and the cyclic AMP responsiveness to thyrotropin. 1982 FEBS Lett. pmid:6185361
Dorsch W et al. Effect of 15-hydroxyeicosatetraenoic acid (15-HETE) on anti-immunoglobulin E- and calcium ionophore-induced histamine release from human leukocytes. Comparison with the effects of eicosatetraynoic acid and nordihydroguaiaretic acid. 1984 Int. Arch. Allergy Appl. Immunol. pmid:6199312
Darius H et al. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis. 1984 Jan-Feb J. Cardiovasc. Pharmacol. pmid:6199592
Wesselius LJ et al. Neutrophil chemotactic activity generation by alveolar macrophages after bleomycin injury. 1984 Am. Rev. Respir. Dis. pmid:6200017
Undem BJ and Buckner CK Evidence that only one type of beta adrenergic receptor mediates inhibition of antigen-induced histamine release from guinea-pig minced lung. 1984 J. Pharmacol. Exp. Ther. pmid:6201606
Furchgott RF The role of endothelium in the responses of vascular smooth muscle to drugs. 1984 Annu. Rev. Pharmacol. Toxicol. pmid:6203480
Fishleder RI and Buckner CK Studies on the relationship between contraction and mediator release produced by ovalbumin in superfused trachea isolated from the actively sensitized guinea pig. 1984 J. Pharmacol. Exp. Ther. pmid:6206223
Badger AM et al. Augmentation of concanavalin A-induced immunosuppression by indomethacin. 1982 Immunopharmacology pmid:6211419
Cragg A et al. Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. 1983 Am. J. Cardiol. pmid:6221648
Spies C et al. Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens. 1980 Naunyn Schmiedebergs Arch. Pharmacol. pmid:6245377
Smolen JE and Weissmann G Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. 1980 Biochem. Pharmacol. pmid:6245654
Smolen JE and Weissmann G Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPB. 1980 Adv Prostaglandin Thromboxane Res pmid:6246788